1069131-95-8

Upstream product

• 110-91-8 morpholine 
• 1069131-94-7 4-(6-fluoro-7-iodo-3H-imidazo[4,5-b]pyridin-2-yl)benzoic acid 
• 212268-13-8 5-fluoro-2,3-pyridinediamine 
• 1069131-91-4 methyl 4-(6-fluoro-3H-imidazo[4,5-b]pyridin-2-yl)benzoate 
• 1069131-92-5 methyl 4-(7-chloro-6-fluoro-3H-imidazo[4,5-b]pyridin-2-yl)benzoate 
• 1069131-93-6 methyl 4-(6-fluoro-7-iodo-3H-imidazo[4,5-b]pyridin-2-yl)benzoate 
• 1679-64-7 Monomethyl terephthalate 

Downstream Products

• 1069131-96-9 6-fluoro-7-iodo-2-[4-(morpholin-4-ylmethyl)phenyl]-3H-imidazo[4,5-b]pyridine 
• 1069131-78-7 6-fluoro-N-(3-methoxypropyl)-2-[4-(morpholin-4-ylmethyl)phenyl]-3H-imidazo[4,5-b]pyridine-7-carboxamide hydrochloride 

Relevant academic research and scientific papers

NEW IMIDAZO[ 4,5-B]PYRIDINE-7-CARBOXAMIDES 704

The present invention relates to new compounds of formula (I) as a free base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.